The University of Rochester Medical Center and GE HealthCare have announced a new Care Alliance designed to enhance healthcare capabilities across URMC’s facilities in upstate New York. The seven-year collaboration will include the development of a center of excellence within URMC’s Imaging Sciences department, the addition of diagnostic tracer production for molecular imaging, and the implementation of standardized patient monitoring across the health system. The partnership builds on a long-standing relationship between the two organizations and is intended to increase operational efficiency, reduce strain on IT and clinical staff, and ensure patients receive consistent, high-quality care throughout UR Medicine.
Health Technology Insights: Ardent Health Announces $50 Million Share Repurchase Program Authorization
Jennifer Harvey, MD, Chair of Imaging Sciences at URMC, said that the Care Alliance supports the institution’s mission to provide exceptional patient care. She explained that the collaboration brings advanced imaging and monitoring solutions to the Finger Lakes region, improving access to critical diagnostics while increasing efficiency. Shane Penzone, Market Vice President at GE HealthCare, highlighted that the partnership combines AI technology, precision care, and data-driven insights to improve patient outcomes and deliver care where patients live.
Health Technology Insights: PCI Pal Launches Secure Payment Solution for Healthcare Sector
The Care Alliance supports URMC’s strategy to advance its Imaging Sciences center of excellence by introducing significant upgrades to diagnostic imaging technology. The program includes new MRI systems and updates to existing equipment with AI-driven applications that reduce imaging noise and scanning time. It also features one of the first Aurora SPECT/CT systems in the United States, a dual-energy CT capable of cardiac scans in a single heartbeat, as well as the addition of LOGIQ E10 ultrasound technology. The agreement allows URMC to implement technology upgrades as new innovations become available, minimizing the need for construction, reducing downtime, and supporting environmental sustainability.
Precision medicine efforts will be enhanced through the addition of a cyclotron at URMC, enabling in-house production of short-lived radioisotopes for PET scans and other advanced imaging techniques. This capability allows patients to receive timely and individualized treatment for conditions such as prostate, ovarian, and thyroid cancers. By producing diagnostic tracers locally, URMC can maintain consistent treatment schedules and provide molecular-level imaging that supports precise therapy planning using platforms such as Omni Legend PET/CT and Aurora SPECT/CT.
The Care Alliance also focuses on standardizing patient monitoring across URMC. The implementation will include bedside monitors, telemetry, central monitoring, and network connectivity solutions using the Carescape ONE patient monitors powered by the Carescape Canvas platform. Michael Scott, MB, ChB, Chair of Anesthesiology and Perioperative Medicine at URMC, stated that the goal is to ensure the right monitor is used for the right patient at the right time. He emphasized that optimizing monitoring systems and introducing wearable technology when appropriate will reduce alarm fatigue, improve patient safety, and simplify workflows for clinical staff. The standardized platform also provides backward and forward compatibility, allowing new technology to be integrated without disrupting existing systems.
Through this Care Alliance, URMC and GE HealthCare aim to expand access to advanced technology, improve patient safety, and enhance operational efficiency, while ensuring that patients across the health system continue to receive exceptional, state-of-the-art care.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 18 November 2025
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
